By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Molecular profiling services210.8M97.51%
Pharma research and development services5.37M2.49%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States801.39M98.69%
International10.64M1.31%